JP2024516392A5 - - Google Patents
Info
- Publication number
- JP2024516392A5 JP2024516392A5 JP2023565419A JP2023565419A JP2024516392A5 JP 2024516392 A5 JP2024516392 A5 JP 2024516392A5 JP 2023565419 A JP2023565419 A JP 2023565419A JP 2023565419 A JP2023565419 A JP 2023565419A JP 2024516392 A5 JP2024516392 A5 JP 2024516392A5
- Authority
- JP
- Japan
- Prior art keywords
- igg
- human
- molecule
- oligomer
- region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163180969P | 2021-04-28 | 2021-04-28 | |
| US63/180,969 | 2021-04-28 | ||
| PCT/US2022/026505 WO2022232246A1 (en) | 2021-04-28 | 2022-04-27 | Multimerization of binding molecules having an antibody constant region variant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516392A JP2024516392A (ja) | 2024-04-15 |
| JP2024516392A5 true JP2024516392A5 (enExample) | 2025-05-02 |
Family
ID=83847261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023565419A Withdrawn JP2024516392A (ja) | 2021-04-28 | 2022-04-27 | 抗体定常領域バリアントを有する結合分子の多量体化 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240209116A1 (enExample) |
| EP (1) | EP4330277A4 (enExample) |
| JP (1) | JP2024516392A (enExample) |
| CN (2) | CN118359707A (enExample) |
| AU (1) | AU2022266780A1 (enExample) |
| CA (1) | CA3216755A1 (enExample) |
| WO (1) | WO2022232246A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022045865A1 (ko) * | 2020-08-31 | 2022-03-03 | (주)메디톡스 | 항-ｖｅｇｆ 육량체 항체, 및 이를 포함하는 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2014MN02293A (enExample) * | 2012-04-20 | 2015-08-07 | Emergent Product Dev Seattle | |
| WO2014006217A1 (en) * | 2012-07-06 | 2014-01-09 | Genmab B.V. | Dimeric protein with triple mutations |
| CA2879814A1 (en) * | 2012-08-02 | 2014-02-06 | Jn Biosciences Llc | Antibodies or fusion proteins multimerized via cysteine mutation and a mu tailpiece |
| ES2719584T3 (es) * | 2014-04-11 | 2019-07-11 | Medimmune Llc | Compuestos conjugados que comprenden anticuerpos modificados por ingeniería genética con cisteína |
| MX2017012805A (es) * | 2015-04-07 | 2018-04-11 | Genentech Inc | Complejo de unión a antígenos con actividad agonista y métodos de uso. |
-
2022
- 2022-04-27 WO PCT/US2022/026505 patent/WO2022232246A1/en not_active Ceased
- 2022-04-27 JP JP2023565419A patent/JP2024516392A/ja not_active Withdrawn
- 2022-04-27 EP EP22796621.5A patent/EP4330277A4/en not_active Withdrawn
- 2022-04-27 AU AU2022266780A patent/AU2022266780A1/en not_active Abandoned
- 2022-04-27 CN CN202410422718.3A patent/CN118359707A/zh active Pending
- 2022-04-27 CN CN202280030416.0A patent/CN117255800A/zh active Pending
- 2022-04-27 US US18/557,273 patent/US20240209116A1/en active Pending
- 2022-04-27 CA CA3216755A patent/CA3216755A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9145454B2 (en) | Monoclonal antibodies for Ebola and Marburg viruses | |
| JP2021524270A5 (enExample) | ||
| JP2019522490A5 (enExample) | ||
| RU2015141428A (ru) | Антитела, связывающие il-4 и/или il-13, и их применение | |
| JP7624185B2 (ja) | 新規抗ｐａｄ４抗体 | |
| JP2021524275A5 (enExample) | ||
| JP6587609B2 (ja) | 強皮症治療のための抗ｃｃｌ２及び抗ｌｏｘｌ２併用療法 | |
| JP7533897B2 (ja) | 融合タンパク質およびその使用 | |
| JP2023505492A5 (enExample) | ||
| JP2024501894A5 (enExample) | ||
| WO2013072514A1 (en) | Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease | |
| JP2023530663A5 (enExample) | ||
| KR102652664B1 (ko) | 조절 t 세포 표면 항원의 에피토프 및 이에 특이적으로 결합하는 항체 | |
| JP2023553697A5 (enExample) | ||
| JP2023528207A5 (enExample) | ||
| JP2018529635A5 (enExample) | ||
| TWI734410B (zh) | 阻礙血管內皮脂酶之酵素活性的人類化單株抗體 | |
| JPWO2020059847A5 (enExample) | ||
| JP2023500248A5 (enExample) | ||
| JP2021181450A (ja) | 細胞内抗原に対して向けられた単一ドメイン抗体 | |
| JP2021508495A5 (enExample) | ||
| JP2022548499A (ja) | 非オピオイド組成物及び疼痛管理のための治療法 | |
| JP2020535811A5 (enExample) | ||
| JP2022534808A5 (enExample) | ||
| EP4174086A1 (en) | Antibody specifically binding to lgals3bp, and use thereof |